Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PROCEPT BioRobotics CorpPRCT · Entity 4831 | Director | June 09, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PROCEPT BioRobotics Corp
Report date June 09, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,791 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 3,315 · Balance 8,791 F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.78 · Expires 2036-06-08 | Direct | 5,853 |
Reported balance
After 2026-06-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-09 · Grant · Acquired 5,853 · Balance 5,853 F2: The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
F2: The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Shockwave Medical, Inc.
Report date February 05, 2024 · Filed February 07, 2024
Section 16 reporting ended · disclosed 2024-02-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,005 |
Ending reported balance
After 2024-02-05 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2024-02-05 · Tax withholding · Disposed 2,208 · Balance 25,524 Row 2 · 2024-02-05 · Tax withholding · Disposed 1,077 · Balance 24,447 Row 3 · 2024-02-05 · Tax withholding · Disposed 213 · Balance 24,234 Row 4 · 2024-02-05 · Sale · Disposed 300 · Balance 23,934 F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023. F2: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $229.12 to $229.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Row 5 · 2024-02-05 · Sale · Disposed 1,703 · Balance 22,231 F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023. F3: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $230.67 to $231.63. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Row 6 · 2024-02-05 · Sale · Disposed 1,226 · Balance 21,005 F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023. F4: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $231.70 to $232.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
Filing footnotes · ownership attribution and instrument terms
F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023.
F2: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $229.12 to $229.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $230.67 to $231.63. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $231.70 to $232.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2020 Filed Nov 13, 2020 01:15 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 1,336 | $4.03 | $5,378.74 |
DisclosureSEC source: 0000950103-20-022100 · dp140819_4-puckett.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| November 10, 2020 Filed Nov 13, 2020 01:15 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 3,295 | $3.42 | $11,255.72 |
DisclosureSEC source: 0000950103-20-022100 · dp140819_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| November 10, 2020 Filed Nov 13, 2020 01:15 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 5,369 | $2.92 | $15,656.00 |
DisclosureSEC source: 0000950103-20-022100 · dp140819_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 01:17 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,620 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000950103-20-021476 · dp140185_4-puckett.xml · derivative · entry 10 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,658 Underlying: Common Stock · 10,000 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F7 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 3/11/19. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 01:17 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 38 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0000950103-20-021476 · dp140185_4-puckett.xml · derivative · entry 9 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 38 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F6 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 7/19/18. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 01:17 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 342 | $0.00 Strike: $3.42 | $0.00 |
DisclosureSEC source: 0000950103-20-021476 · dp140185_4-puckett.xml · derivative · entry 8 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,369 Underlying: Common Stock · 342 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 7/21/17. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 01:17 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 20 | $69.48 | $1,389.60 |
DisclosureSEC source: 0000950103-20-021476 · dp140185_4-puckett.xml · nonDerivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,308 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 01:17 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 360 | $68.53 | $24,670.80 |
DisclosureSEC source: 0000950103-20-021476 · dp140185_4-puckett.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,328 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $68.25 to $68.98. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 01:17 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 820 | $67.53 | $55,374.60 |
DisclosureSEC source: 0000950103-20-021476 · dp140185_4-puckett.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,688 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $67.23 to $68.19. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 01:17 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 800 | $66.81 | $53,448.00 |
DisclosureSEC source: 0000950103-20-021476 · dp140185_4-puckett.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,508 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $66.22 to $67.21. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 01:17 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 1,620 | $17.00 | $27,540.00 |
DisclosureSEC source: 0000950103-20-021476 · dp140185_4-puckett.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 01:17 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 38 | $4.03 | $152.99 |
DisclosureSEC source: 0000950103-20-021476 · dp140185_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 01:17 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 342 | $3.42 | $1,168.27 |
DisclosureSEC source: 0000950103-20-021476 · dp140185_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| October 15, 2020 Filed Oct 17, 2020 01:27 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000950103-20-020208 · dp138866_4-puckett.xml · derivative · entry 13 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,369 Underlying: Common Stock · 10,000 shares Expires 2026-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F7 · derivative.exercise_date: Twenty-Five percent of the shares subject to the option vested on 4/15/17 and the balance of the shares shall vest in equal monthly installments thereafter for 36 months. Read SEC document |
| October 15, 2020 Filed Oct 17, 2020 01:27 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 987 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0000950103-20-020208 · dp138866_4-puckett.xml · derivative · entry 12 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,148 Underlying: Common Stock · 987 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F6 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 7/19/18. Read SEC document |
| October 15, 2020 Filed Oct 17, 2020 01:27 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 672 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0000950103-20-020208 · dp138866_4-puckett.xml · derivative · entry 11 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,135 Underlying: Common Stock · 672 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F6 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 7/19/18. Read SEC document |
| October 15, 2020 Filed Oct 17, 2020 01:27 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 341 | $0.00 Strike: $3.42 | $0.00 |
DisclosureSEC source: 0000950103-20-020208 · dp138866_4-puckett.xml · derivative · entry 10 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,711 Underlying: Common Stock · 341 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 7/21/17. Read SEC document |
| October 15, 2020 Filed Oct 17, 2020 01:27 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 100 | $74.93 | $7,493.00 |
DisclosureSEC source: 0000950103-20-020208 · dp138866_4-puckett.xml · nonDerivative · entry 9 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,308 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| October 15, 2020 Filed Oct 17, 2020 01:27 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 10,700 | $74.49 | $797,043.00 |
DisclosureSEC source: 0000950103-20-020208 · dp138866_4-puckett.xml · nonDerivative · entry 8 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,408 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $73.87 to $74.69. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| October 15, 2020 Filed Oct 17, 2020 01:27 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 600 | $73.22 | $43,932.00 |
DisclosureSEC source: 0000950103-20-020208 · dp138866_4-puckett.xml · nonDerivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,108 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $72.87 to $73.77. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| October 15, 2020 Filed Oct 17, 2020 01:27 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 500 | $72.10 | $36,050.00 |
DisclosureSEC source: 0000950103-20-020208 · dp138866_4-puckett.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,708 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $71.67 to $72.50. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| October 15, 2020 Filed Oct 17, 2020 01:27 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 100 | $70.51 | $7,051.00 |
DisclosureSEC source: 0000950103-20-020208 · dp138866_4-puckett.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,208 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| October 15, 2020 Filed Oct 17, 2020 01:27 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 10,000 | $2.20 | $21,960.00 |
DisclosureSEC source: 0000950103-20-020208 · dp138866_4-puckett.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| October 15, 2020 Filed Oct 17, 2020 01:27 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 987 | $4.03 | $3,973.66 |
DisclosureSEC source: 0000950103-20-020208 · dp138866_4-puckett.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| October 15, 2020 Filed Oct 17, 2020 01:27 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 672 | $4.03 | $2,705.47 |
DisclosureSEC source: 0000950103-20-020208 · dp138866_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| October 15, 2020 Filed Oct 17, 2020 01:27 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 341 | $3.42 | $1,164.86 |
DisclosureSEC source: 0000950103-20-020208 · dp138866_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| August 24, 2020 Filed Aug 25, 2020 23:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 527 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000950103-20-016415 · dp135056_4-puckett.xml · derivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,369 Underlying: Common Stock · 527 shares Expires 2026-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · derivative.exercise_date: Twenty-Five percent of the shares subject to the option vested on 4/15/17 and the balance of the shares shall vest in equal monthly installments thereafter for 36 months. Read SEC document |
| August 24, 2020 Filed Aug 25, 2020 23:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 527 | $60.00 | $31,620.00 |
DisclosureSEC source: 0000950103-20-016415 · dp135056_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,308 F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| August 24, 2020 Filed Aug 25, 2020 23:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 527 | $2.20 | $1,157.29 |
DisclosureSEC source: 0000950103-20-016415 · dp135056_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| August 21, 2020 Filed Aug 22, 2020 01:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,866 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000950103-20-016248 · dp134886_4-puckett.xml · derivative · entry 8 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,896 Underlying: Common Stock · 3,866 shares Expires 2026-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · derivative.exercise_date: Twenty-Five percent of the shares subject to the option vested on 4/15/17 and the balance of the shares shall vest in equal monthly installments thereafter for 36 months. Read SEC document |
| August 21, 2020 Filed Aug 22, 2020 01:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 3,866 | $60.02 | $232,037.32 |
DisclosureSEC source: 0000950103-20-016248 · dp134886_4-puckett.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,308 F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $60.00 to $60.20. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 21, 2020 Filed Aug 22, 2020 01:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 3,866 | $2.20 | $8,489.74 |
DisclosureSEC source: 0000950103-20-016248 · dp134886_4-puckett.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| August 20, 2020 Filed Aug 22, 2020 01:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 803 | $0.00 Strike: $3.42 | $0.00 |
DisclosureSEC source: 0000950103-20-016248 · dp134886_4-puckett.xml · derivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,052 Underlying: Common Stock · 803 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 7/21/17. Read SEC document |
| August 20, 2020 Filed Aug 22, 2020 01:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,804 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000950103-20-016248 · dp134886_4-puckett.xml · derivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,762 Underlying: Common Stock · 4,804 shares Expires 2026-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · derivative.exercise_date: Twenty-Five percent of the shares subject to the option vested on 4/15/17 and the balance of the shares shall vest in equal monthly installments thereafter for 36 months. Read SEC document |
| August 20, 2020 Filed Aug 22, 2020 01:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 5,607 | $60.04 | $336,644.28 |
DisclosureSEC source: 0000950103-20-016248 · dp134886_4-puckett.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,308 F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $60.00 to $60.19. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 20, 2020 Filed Aug 22, 2020 01:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 803 | $3.42 | $2,743.05 |
DisclosureSEC source: 0000950103-20-016248 · dp134886_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| August 20, 2020 Filed Aug 22, 2020 01:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 4,804 | $2.20 | $10,549.58 |
DisclosureSEC source: 0000950103-20-016248 · dp134886_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 01:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,430 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000950103-20-015372 · dp134024_4-puckett.xml · derivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,566 Underlying: Common Stock · 1,430 shares Expires 2026-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · derivative.exercise_date: Twenty-Five percent of the shares subject to the option vested on 4/15/17 and the balance of the shares shall vest in equal monthly installments thereafter for 36 months. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 01:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 1,430 | $50.01 | $71,514.30 |
DisclosureSEC source: 0000950103-20-015372 · dp134024_4-puckett.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,308 F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $50.00 to $50.01. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 01:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 1,430 | $2.20 | $3,140.28 |
DisclosureSEC source: 0000950103-20-015372 · dp134024_4-puckett.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| August 03, 2020 Filed Aug 6, 2020 01:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,570 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000950103-20-015372 · dp134024_4-puckett.xml · derivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,996 Underlying: Common Stock · 8,570 shares Expires 2026-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · derivative.exercise_date: Twenty-Five percent of the shares subject to the option vested on 4/15/17 and the balance of the shares shall vest in equal monthly installments thereafter for 36 months. Read SEC document |
| August 03, 2020 Filed Aug 6, 2020 01:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 8,570 | $50.02 | $428,671.40 |
DisclosureSEC source: 0000950103-20-015372 · dp134024_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,308 F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $50.00 to $50.02. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 03, 2020 Filed Aug 6, 2020 01:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 8,570 | $2.20 | $18,819.72 |
DisclosureSEC source: 0000950103-20-015372 · dp134024_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| April 17, 2020 Filed Apr 21, 2020 20:50 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Tax withholdingCommon Stock | 692 | $38.22 | $26,448.24 |
DisclosureSEC source: 0000950103-20-007875 · dp126521_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,308 Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 01:46 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-20-002992 · dp121626_4-puckett.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 01:46 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000950103-20-002992 · dp121626_4-puckett.xml · derivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,566 Underlying: Common Stock · 50,000 shares Expires 2026-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F6 · derivative.exercise_date: Twenty-Five percent of the shares subject to the option vested on 4/15/17 and the balance of the shares shall vest in equal monthly installments thereafter for 36 months. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 01:46 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 600 | $46.05 | $27,631.02 |
DisclosureSEC source: 0000950103-20-002992 · dp121626_4-puckett.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $46.04 to $46.09. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 01:46 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 5,656 | $45.28 | $256,077.10 |
DisclosureSEC source: 0000950103-20-002992 · dp121626_4-puckett.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,600 F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $44.95 to $45.92. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 01:46 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 31,204 | $44.24 | $1,380,518.01 |
DisclosureSEC source: 0000950103-20-002992 · dp121626_4-puckett.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,256 F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $43.95 to $44.91. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 01:46 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 12,540 | $43.73 | $548,408.06 |
DisclosureSEC source: 0000950103-20-002992 · dp121626_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,460 F1 · kind: This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $42.95 to $43.94. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.